Citation

Muthukaman N, Deshmukh S, Tambe M, Pisal D, Tondlekar S, Shaikh M, Sarode N, Kattige VG, Sawant P, Pisat M, Karande V, Honnegowda S, Kulkarni A, Behera D, Jadhav SB, Sangana RR, Gudi GS, Khairatkar-Joshi N, Gharat LA.: Alleviating CYP and hERG liabilities by structure optimization of dihydrofuran-fused tricyclic benzo[d]imidazole series - Potent, selective and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-2. Bioorg Med Chem Lett, Volume 28 (7), 2018

Authors

Behera D, Deshmukh S, Gharat LA., Gudi GS, Honnegowda S, Jadhav SB, Karande V, Kattige VG, Khairatkar-Joshi N, Kulkarni A, Muthukaman N, Pisal D, Pisat M, Sangana RR, Sarode N, Sawant P, Shaikh M, Tambe M, Tondlekar S

Journal

Bioorg Med Chem Lett

Year

2018

DOI

10.1016/j.bmcl.2018.02.048

PubMed

29519738

Machine-readable

REST APIRDF